Vericiguat
| CAS No. | 1350653-20-1 |
|---|---|
| MDL No. | MFCD28502029 |
| MF | C19H16F2N8O2 |
| MW | 426.40 |
| InChI Key | QZFHIXARHDBPBY-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Vericiguat is a 5-fluoro-1H-pyrazolo[3,4-b]pyridine derivative with a 2-fluorobenzyl group substituting the amino hydrogen at position 1 and a 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl group substituting the hydrogen at position 3. It functions as a soluble guanylate cyclase stimulator and is used in the treatment of chronic heart failure. Vericiguat acts as a soluble guanylate cyclase activator, vasodilator, and antihypertensive agent. It belongs to the classes of aminopyrimidine, pyrazolopyridine, carbamate ester, and organofluorine compounds.
| CAS No. | 1350653-20-1 |
|---|---|
| Product Name | Vericiguat |
Health HazardSignal Word:Danger
HCode:H372
PCode:P260-P264-P270-P319-P501
